Skip to main content
SpringerLink
Log in

Adjuvant Therapies and Markers of Post-Surgical Minimal Residual Disease I

Markers and General Problems of Cancer Adjuvant Therapies

  • Book
  • © 1979

Overview

Editors:
  1. Gianni Bonadonna

    1. Istituto Nazionale dei Tumori, Milano, Italy

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

  2. Georges Mathé

    1. Institut de Cancérologie et d’Immunogénétique, Hôpital Paul-Brousse, Villejuif, France

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

  3. Sydney E. Salmon

    1. University of Arizona Cancer Center, Tucson, USA

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

Part of the book series: Recent Results in Cancer Research (RECENTCANCER, volume 67)

This is a preview of subscription content, log in via an institution to check access.

Access this book

Log in via an institution
eBook USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (20 chapters)

  1. Front Matter

    Pages I-XVIII
    Download chapter PDF

  2. Introduction

    1. Introduction

      • P. Denoix, G. Mathé
      Pages 1-2

  3. Incidence, Kinetics and Markers of Post-Surgical Minimal Residual Disease

    1. Front Matter

      Pages 3-3
      Download chapter PDF

    2. Kinetics of Minimal Residual Disease

      • S. E. Salmon
      Pages 5-15

    3. Ectopic Production of ACTH, Lipotropin, and β-Endorphin by Human Cancer Cells. Structurally Related Tumor Markers

      • X. Y. Bertagna, W. E. Nicholson, K. Tanaka, C. D. Mount, G. D. Sorenson, O. S. Pettengill et al.
      Pages 16-25

    4. Prognostic Value of Postoperative Blood Levels of Carcinoembryonic Antigen (CEA) in Breast Cancer

      • R. E. Myers, D. J. A. Sutherland, J. W. Meakin, D. G. Malkin, J. A. Kellen, A. Malkin
      Pages 26-32

    5. α-Fetoprotein (αFP) as a Marker for Hepatoma and Yolk Sac Tumors

      • D. Buffe, C. Rimbaut
      Pages 33-38

    6. Casein and Breast Cancer

      • J. C. Hendrick, P. F. Zangerle, P. Franchimont
      Pages 39-44

    7. Prostatic Acid Phosphatase and Prostatic Cancer

      • A. G. Foti, J. F. Cooper, H. Herschman
      Pages 45-49

    8. Sialyl Transferase Activity: A Serum Enzyme Marker in the Follow-Up of Cancer Patients

      • U. Ganzinger, K. Moser
      Pages 50-55

    9. Evidence for Natural Antibodies (IgG) to Polyamines in Human Sera

      • A. M. Roch, G. A. Quash, J. P. Ripoll, S. Saez
      Pages 56-62

    10. Dynamic and Composition of Cellular Membranes and Serum Lipids in Malignant Disorders

      • C. Rosenfeld, C. Jasmin, G. Mathé, M. Inbar
      Pages 63-77

    11. Biologic Markers in Neuroblastoma

      • R. Maurus, J. Otten
      Pages 78-84

    12. Immune Complexes in Breast Carcinoma

      • R. W. Baldwin, K. Höffken, R. A. Robins
      Pages 85-87

    13. Serum Leukocyte Inhibitory Factor in Cancer Patients (Serum LIF)

      • A. Fassas, M. Bruley-Rosset
      Pages 88-92

    14. Clinical Evaluation of the Modified Makari Skin Test in Minimal Residual Malignant Disease

      • D. E. H. Tee
      Pages 93-96

    15. Multiparametric Markers in the Monitoring of Cancer

      • E. H. Cooper
      Pages 97-103

  4. Adjuvant Therapies of Post-Surgical Minimal Residual Disease

    1. Front Matter

      Pages 105-105
      Download chapter PDF

    2. Rational and Experimental Basis of Post-Surgical Residual Therapies

      1. A. Rational and Experimental Basis of Post-Surgical Residual Therapies
        • M. Tubiana
        Pages 107-114
      2. Possible Drawback of Radiotherapy: Rational and Experimental Bases of Post-Surgical Therapies
        • J. Stjernswärd
        Pages 115-118
Back to top

Keywords

About this book

P. Denoix and G. Mathe Approximately 70% of cancer patients relapse after surgery before the 5th year and, in most cases, for example in breast carcinoma, they relapse still later up to the 20th year. For some considerable time, the strategy of cancer treatment has been limited to the sophistication of surgery-radiotherapy combinations that maximally decreased the incidence of local and regional relapses in sites that were within their reach. Today, the practice of clinical oncology is unthinkable without the active participation of the medical oncologist. He is the "third man" of the clinical oncology team, and he has recently focused attention on the fact that most relapses arise from distant metastases due to the proliferation of cells seeded there after having left the primary tumor site at the time of operation and, hence, are inaccessible to any form oflocal and/or regional treatment. On this evidence, medical oncologists have proposed the application of medical treatments for disseminated minimal residual disease (MRD). They have two available means: chemother­ apy and immunotherapy. Medical oncologists in general can be divided into three groups: chemotherapists, immunotherapists, and chemoimmunotherapists. The pure chemotherapists, who had already cured some malignant neoplasias such as Hodgkin's disease, acute lymphoid leukemia, placental choriocarcinoma, and Wilms' tumor, thought they might have the means of attacking the residual disease of common cancers.

Editors and Affiliations

  • Istituto Nazionale dei Tumori, Milano, Italy

    Gianni Bonadonna

  • Institut de Cancérologie et d’Immunogénétique, Hôpital Paul-Brousse, Villejuif, France

    Georges Mathé

  • University of Arizona Cancer Center, Tucson, USA

    Sydney E. Salmon

Bibliographic Information

  • Book Title: Adjuvant Therapies and Markers of Post-Surgical Minimal Residual Disease I

  • Book Subtitle: Markers and General Problems of Cancer Adjuvant Therapies

  • Editors: Gianni Bonadonna, Georges Mathé, Sydney E. Salmon

  • Series Title: Recent Results in Cancer Research

  • DOI: https://doi.org/10.1007/978-3-642-81320-7

  • Publisher: Springer Berlin, Heidelberg

  • eBook Packages: Springer Book Archive

  • Copyright Information: Springer-Verlag Berlin · Heidelberg 1979

  • Softcover ISBN: 978-3-642-81322-1Published: 08 December 2011

  • eBook ISBN: 978-3-642-81320-7Published: 06 December 2012

  • Series ISSN: 0080-0015

  • Series E-ISSN: 2197-6767

  • Edition Number: 1

  • Number of Pages: XVIII, 154

  • Number of Illustrations: 6 b/w illustrations

  • Topics: Oncology

Publish with us

Policies and ethics

Back to top

Search

Navigation